Showing results 1 to 1 of 1
| Title | Author(s) | Issue Date | |
|---|---|---|---|
VIR-2218 (elebsiran) plus pegylated interferon-alfa-2a in participants with chronic hepatitis B virus infection: a phase 2 study Journal:The Lancet Gastroenterology & Hepatology | 1-Dec-2024 |